Glaukos Total Liabilities 2014-2023 | GKOS
Glaukos total liabilities from 2014 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Glaukos Annual Total Liabilities
(Millions of US $) |
| 2022 |
$472 |
| 2021 |
$463 |
| 2020 |
$338 |
| 2019 |
$145 |
| 2018 |
$33 |
| 2017 |
$28 |
| 2016 |
$17 |
| 2015 |
$21 |
| 2014 |
$30 |
| 2013 |
$24 |
Glaukos Quarterly Total Liabilities
(Millions of US $) |
| 2023-03-31 |
$464 |
| 2022-12-31 |
$472 |
| 2022-09-30 |
$460 |
| 2022-06-30 |
$469 |
| 2022-03-31 |
$455 |
| 2021-12-31 |
$463 |
| 2021-09-30 |
$463 |
| 2021-06-30 |
$459 |
| 2021-03-31 |
$433 |
| 2020-12-31 |
$338 |
| 2020-09-30 |
$333 |
| 2020-06-30 |
$333 |
| 2020-03-31 |
$138 |
| 2019-12-31 |
$145 |
| 2019-09-30 |
$117 |
| 2019-06-30 |
$114 |
| 2019-03-31 |
$43 |
| 2018-12-31 |
$33 |
| 2018-09-30 |
$27 |
| 2018-06-30 |
$23 |
| 2018-03-31 |
$20 |
| 2017-12-31 |
$28 |
| 2017-09-30 |
$21 |
| 2017-06-30 |
$20 |
| 2017-03-31 |
$15 |
| 2016-12-31 |
$17 |
| 2016-09-30 |
$19 |
| 2016-06-30 |
$19 |
| 2016-03-31 |
$18 |
| 2015-12-31 |
$21 |
| 2015-09-30 |
$23 |
| 2015-06-30 |
$33 |
| 2015-03-31 |
$33 |
| 2014-12-31 |
$30 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$24 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$2.836B |
$0.283B |
|
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
|
